Schroder Investment Management Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.81M | Sell |
110,213
-48,125
| -30% | -$2.1M | ﹤0.01% | 769 |
|
|
2025
Q1 | $4.69M | Sell |
158,338
-5,558
| -3% | -$165K | ﹤0.01% | 766 |
|
|
2024
Q4 | $6.44M | Buy |
163,896
+20,204
| +14% | +$794K | 0.01% | 725 |
|
|
2024
Q3 | $7M | Sell |
143,692
-18,509
| -11% | -$901K | 0.01% | 732 |
|
|
2024
Q2 | $4.84M | Buy |
162,201
+41,354
| +34% | +$1.23M | 0.01% | 789 |
|
|
2024
Q1 | $4.86M | Sell |
120,847
-64,452
| -35% | -$2.59M | 0.01% | 786 |
|
|
2023
Q4 | $4.72M | Sell |
185,299
-42,281
| -19% | -$1.08M | 0.01% | 775 |
|
|
2023
Q3 | $3.16M | Buy |
227,580
+2,749
| +1% | +$38.2K | ﹤0.01% | 839 |
|
|
2023
Q2 | $5.17M | Buy |
+224,831
| New | +$5.17M | 0.01% | 778 |
|
|
2022
Q1 | – | Sell |
-28,989
| Closed | -$1.84M | – | 1480 |
|
|
2021
Q4 | $1.84M | Buy |
+28,989
| New | +$1.84M | ﹤0.01% | 944 |
|